HK1203512A1 - Compounds and methods for the treatment of cancer - Google Patents

Compounds and methods for the treatment of cancer

Info

Publication number
HK1203512A1
HK1203512A1 HK15103803.4A HK15103803A HK1203512A1 HK 1203512 A1 HK1203512 A1 HK 1203512A1 HK 15103803 A HK15103803 A HK 15103803A HK 1203512 A1 HK1203512 A1 HK 1203512A1
Authority
HK
Hong Kong
Prior art keywords
cancer
compounds
treatment
methods
Prior art date
Application number
HK15103803.4A
Other languages
English (en)
Chinese (zh)
Inventor
‧辛加洛
Original Assignee
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys filed Critical Texas A & M Univ Sys
Publication of HK1203512A1 publication Critical patent/HK1203512A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • C07F9/82—Arsenic compounds containing one or more pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15103803.4A 2006-01-13 2009-09-25 Compounds and methods for the treatment of cancer HK1203512A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75921806P 2006-01-13 2006-01-13
US76300806P 2006-01-26 2006-01-26

Publications (1)

Publication Number Publication Date
HK1203512A1 true HK1203512A1 (en) 2015-10-30

Family

ID=38158019

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15103803.4A HK1203512A1 (en) 2006-01-13 2009-09-25 Compounds and methods for the treatment of cancer
HK09108874.5A HK1130804A1 (en) 2006-01-13 2009-09-25 Compounds and methods for the treatment of cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK09108874.5A HK1130804A1 (en) 2006-01-13 2009-09-25 Compounds and methods for the treatment of cancer

Country Status (10)

Country Link
US (2) US8222440B2 (ja)
EP (1) EP1979368B1 (ja)
JP (1) JP5202332B2 (ja)
KR (2) KR20130129316A (ja)
CN (2) CN101395166B (ja)
AU (1) AU2007204831B2 (ja)
CA (1) CA2636793C (ja)
HK (2) HK1203512A1 (ja)
IL (3) IL192738A0 (ja)
WO (1) WO2007082104A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101874034A (zh) * 2007-12-12 2010-10-27 Zio医药肿瘤学公司 用于治疗癌症的化合物和方法
BRPI0918407A2 (pt) 2008-08-20 2015-11-24 Ziopharm Oncology Inc compostos organoarsênicos e métodos para o tratamento de câncer
WO2015085208A1 (en) * 2013-12-05 2015-06-11 Solasia Pharma K.K. Compounds and methods for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399480T3 (es) 1997-11-10 2013-04-01 Memorial Sloan-Kettering Cancer Center Procedimiento de producción de formulaciones de trióxido de arsénico
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
EP2420229A1 (en) * 2002-01-07 2012-02-22 Board Of Regents, University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
TW201350113A (zh) 2004-07-16 2013-12-16 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物

Also Published As

Publication number Publication date
CN101395166B (zh) 2014-07-09
JP2009527463A (ja) 2009-07-30
CN101395166A (zh) 2009-03-25
WO2007082104A2 (en) 2007-07-19
IL192738A0 (en) 2009-02-11
AU2007204831A1 (en) 2007-07-19
HK1130804A1 (en) 2010-01-08
KR20080106897A (ko) 2008-12-09
KR101471498B1 (ko) 2014-12-10
CN104109177A (zh) 2014-10-22
EP1979368B1 (en) 2014-12-24
US8222440B2 (en) 2012-07-17
WO2007082104A3 (en) 2007-10-18
EP1979368A2 (en) 2008-10-15
US20130143950A1 (en) 2013-06-06
IL226363A0 (en) 2013-06-27
KR20130129316A (ko) 2013-11-27
CA2636793A1 (en) 2007-07-19
US20090233894A1 (en) 2009-09-17
JP5202332B2 (ja) 2013-06-05
CA2636793C (en) 2014-07-08
AU2007204831B2 (en) 2013-10-03
IL226362A0 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
IL248204A0 (en) Combined treatment of tumors expressing 38cd
IL188746A0 (en) Treatment of cancer
IL197315A0 (en) Treatment of cancer
EP1994181A4 (en) IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
EP1991230A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
PT2101731T (pt) Endoxifeno para utilização no tratamento de cancro
WO2007081751A9 (en) Compositions and methods for the treatment of cancer
GB0604471D0 (en) Device and method for the treatment of tumours
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
HK1117780A1 (en) Compounds and methods for the treatment of cancer
IL199689A0 (en) Compounds and method for treatment of cancer
EP2144887A4 (en) PHARMACEUTICAL FORMS AND METHOD FOR THE TREATMENT OF CANCER
HK1212218A1 (en) Organoarsenic compounds and methods for the treatment of cancer
EP2150270A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
EP2225226A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2007790A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
GB0517387D0 (en) Combinations for the treatment of cancer
EP1904088A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
IL226363A0 (en) Compounds and methods for treating cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0520067D0 (en) Treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
HK1209754A1 (en) Compounds and methods for the treatment of cancer